Vimarsana
Biggest News Aggregation in the World

Bita Sehat News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Bita Sehat. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Bita Sehat Today - Breaking & Trending Today

MinervaX announces 72M EUR financing to advance development of novel vaccine against Group B Streptococcus - Vimarsana News

MinervaX announces 72M EUR financing to advance development of novel vaccine against Group B Streptococcus

/PRNewswire/ -- MinervaX ApS, a privately held Danish biotechnology company developing a novel vaccine against Group B Streptococcus (GBS), today announces the...

MinervaX Raises €72M Financing - Vimarsana News

MinervaX Raises €72M Financing

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

MinervaX raises upsized EUR 47.4M (USD 57M) Series B to advance its novel Group B Streptococcus vaccine through mid-stage clinical trials - Vimarsana News

MinervaX raises upsized EUR 47.4M (USD 57M) Series B to advance its novel Group B Streptococcus vaccine through mid-stage clinical trials

Share: COPENHAGEN, Denmark, Dec. 15, 2020 /PRNewswire/ -- MinervaX, a privately held Danish biotechnology company developing a novel vaccine against Group B Streptococcus (GBS), announced today that it has raised an upsized EUR 47.4 million Series B financing. The round included new investors Sanofi Ventures, Wellington Partners, Adjuvant Capital, and Industrifonden, along with existing investors Novo Holdings REPAIR Impact Fund, Sunstone Life Science Ventures, and LF Investment. Proceeds will advance the clinical development of MinervaX's novel GBS vaccine through Phase II clinical trials,...